Australia Stock Exchange release from NEUROSCIENTIFIC : Completion of Safety Pharmacology Studies
17/10/2021 23:42
Australia Stock Exchange release from NEUROSCIENTIFIC NSB.AX : Completion of Safety Pharmacology Studies
Recent news on Miro Sciences
See all newsBrief: Neuroscientific Biopharmaceuticals Appoints Chris Knee As CFO
Brief: Neuroscientific Biopharmaceuticals Seeks Trading Halt
Australia's NeuroScientific Biopharmaceuticals surges on positive clinical results
Brief: Neuroscientific Biopharmaceuticals Requests Trading Halt
Brief: Neuroscientific Biopharmaceuticals Appoints Nathan Smith As CEO